The solution uses machine learning and predictive modelling to accurately estimate protocol accrual. Credit: Free-Photos from Pixabay.

US-based Advarra has launched Insights Accrual Prediction Platform, a new next-generation accrual prediction solution for clinical trials.

Available through the Advarra Insights business intelligence platform, the new solution uses machine learning and predictive modelling to accurately estimate protocol accrual, strengthening clinical research success.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Built using a proprietary algorithm, it is planned to be initially launched to pilot customers as part of the Insights 2021R3 product release.

It allows clinical trial administrators to run hundreds of data points to analyse past accrual rates to make decision about which studies to activate, and also helps to predict the number of participants each study is likely to enrol.

The company noted that the new platform is part of the Advarra Insights business intelligence solution which is designed to quickly provide data-based answers to complex research questions.

University of Wisconsin Carbone Cancer Center Clinical Research assistant director Sarah Stewart said: “Unfortunately, resources to activate, open, and maintain clinical trials are limited and zero-accruing protocols are all too common.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The Insights Accrual Prediction platform has the potential to be extremely valuable in preserving and redirecting precious resources towards successful trials.

“I look forward to the day when our organisation is regularly using the platform to make data-driven decisions to determine which trials to pursue, enabling us to focus on trials that will offer the most opportunity to our cancer patients.”

Advarra Insights synchronises the data by connecting to the customer’s OnCore Enterprise Research System CTMS environment to populate intuitive dashboards and reports.

This helps to identify areas required for intervention to provide a holistic showcase clinical research portfolio of organisation to internal and external leadership.